|Trial Design||Double blind|
|Trial Length||6+ Months|
|Number of Subjects||379|
|Age Range||45-64, 65+|
|Body Types||Overweight, Average|
500mcg of phylloquinone daily for 3 years was unable to significantly reduce IL-6 concentrations despite being inversely correlated at baseline, and both C-reactive protein and OPG appeared to also be unaffected with treatment.